Income Tax Expense (Benefit) of REGENEREX PHARMA, INC. from 31 Mar 2025 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
REGENEREX PHARMA, INC. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2025 to 30 Sep 2025.
  • REGENEREX PHARMA, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $50.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

REGENEREX PHARMA, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $50 01 Jul 2025 30 Sep 2025 10-Q 17 Nov 2025 2025 Q2
Q2 2025 $113 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2024 Q1

REGENEREX PHARMA, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,717 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.